Gene: ETAA1
Official Full Name: ETAA1 activator of ATR kinaseprovided by HGNC
Gene Summary: Enables protein serine/threonine kinase activator activity. Involved in several processes, including positive regulation of protein serine/threonine kinase activity; regulation of cell cycle phase transition; and replication fork processing. Located in cytosol; nuclear replication fork; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21749 | ETAA1 Knockout cell line (HeLa) | Human | ETAA1 | 1:3~1:6 | Negative | Online Inquiry |
KO21750 | ETAA1 Knockout cell line (HCT 116) | Human | ETAA1 | 1:2~1:4 | Negative | Online Inquiry |
KO21751 | ETAA1 Knockout cell line (HEK293) | Human | ETAA1 | 1:3~1:6 | Negative | Online Inquiry |
KO21752 | ETAA1 Knockout cell line (A549) | Human | ETAA1 | 1:3~1:4 | Negative | Online Inquiry |
ETAA1 Gene Knockout Cell Lines are specialized cellular models engineered to lack the ETAA1 (Enhancer of Tyrosine Kinase Activation 1) gene, a critical component involved in the cellular response to DNA damage and repair. These knockout cell lines provide researchers with invaluable tools for investigating the intricate pathways governing cellular integrity, particularly in the context of oncogenesis and tumor progression, where DNA repair mechanisms are often dysregulated.
The primary function of the ETAA1 gene involves modulating signaling pathways that control the cellular response to genotoxic stress. By utilizing CRISPR-Cas9 technology to delete the ETAA1 gene, these knockout cell lines create conditions under which researchers can analyze the resultant phenotypic changes related to DNA damage response mechanisms. When subjected to ionizing radiation or other DNA-damaging agents, these cells exhibit altered proliferation rates, apoptosis, and sensitivity to chemotherapeutic agents, thus offering insights into how ETAA1 influences tumor cell survival and therapeutic resistance.
The scientific importance of ETAA1 Gene Knockout Cell Lines extends into both fundamental research and clinical applications. In addition to enhancing our understanding of DNA repair pathways, these models are crucial for drug discovery and development, particularly in identifying novel treatment strategies for cancers characterized by aberrant DNA repair mechanisms. They allow for the screening of compounds targeting pathways that are altered due to the loss of ETAA1 function, thus accelerating the development of precision medicine approaches.
Compared to alternative cell lines, ETAA1 knockout models provide a unique platform to uncover specific interactions and downstream effects associated with the absence of this gene, which may not be as evident in wild-type models. This specificity offers enhanced experimental accuracy and relevance, enabling researchers to explore targeted therapies and specific responses to DNA damage with greater detail.
For researchers and clinicians seeking to deepen their understanding of DNA damage responses or to find effective treatments for resistant cancers, ETAA1 Gene Knockout Cell Lines represent a vital addition to their experimental toolkit. Our commitment to advancing scientific research is reflected in our precise engineering of these cell lines, backed by extensive validation. We are dedicated to providing high-quality biological products that empower the scientific community to push the boundaries of discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.